Company profile for OncoMed Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

OncoMed's clinical programs and ongoing research efforts are focused on novel anti-cancer and immuno-oncology strategies. Cancer is believed to thrive, in part, because of a number of cellular mechanisms that aid in the evasion of immune response. Such mechanisms of immune system evasion include masking or reducing the expression of tumor antigens to avoid detection, recruiting T-cell suppressor cells or releasing inhibitory m...
OncoMed's clinical programs and ongoing research efforts are focused on novel anti-cancer and immuno-oncology strategies. Cancer is believed to thrive, in part, because of a number of cellular mechanisms that aid in the evasion of immune response. Such mechanisms of immune system evasion include masking or reducing the expression of tumor antigens to avoid detection, recruiting T-cell suppressor cells or releasing inhibitory molecules that suppress immune activation, inducing conditions in the tumor microenvironment that promote tumor cell proliferation and survival, and a number of other factors.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
800 Chesapeake Drive Redwood City, CA 94063
Telephone
Telephone
+1-650-995-8200
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2021/04/30/2220584/0/en/Mereo-BioPharma-and-Cancer-Focus-Fund-Announce-Partnership-for-Phase-1b-2-Study-of-Etigilimab-in-Clear-Cell-Ovarian-Cancer.html

GLOBENEWSWIRE
30 Apr 2021
Notice of AGM
Notice of AGM

16 Apr 2021

// PRESS RELEASE

https://www.mereobiopharma.com/news-and-events/press-releases/2021/notice-of-agm/notice-of-agm/

PRESS RELEASE
16 Apr 2021

https://www.mereobiopharma.com/news-and-events/press-releases/2021/mereo-biopharma-to-present-at-the-20th-annual-needham-virtual-healthcare-conference/mereo-biopharma-to-present-at-the-20th-annual-needham-virtual-healthcare-conference/

PRESS RELEASE
06 Apr 2021

https://www.mereobiopharma.com/news-and-events/press-releases/2021/mereo-biopharma-to-participate-in-a-fireside-chat-at-the-10th-annual-svb-leerink-global-healthcare-conference/mereo-to-participate-in-svb-leerink-healthcare-conference-fireside-chat/

PRESS RELEASE
18 Feb 2021

https://www.mereobiopharma.com/news-and-events/press-releases/2021/closing-of-public-offering-full-exercise-of-over-allotment-option/closing-of-public-offering-full-exercise-of-over-allotment-option/

PRESS RELEASE
12 Feb 2021

https://www.mereobiopharma.com/news-and-events/press-releases/2021/mereo-biopharma-group-plc-announces-pricing-of-public-offering-of-ads/mereo-biopharma-group-plc-announces-pricing-of-public-offering-of-ads/

PRESS RELEASE
10 Feb 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty